EUVIMEDDescoperă EUVIMED
Crossref

Tobramycin and antiglaucoma agents as increasing culprits of periorbital allergic contact dermatitis from topical ophthalmic medications: A 24‐year study from Turkey

Esen Özkaya iD, Zeynep Keskinkaya iD, Goncagül Babuna Kobaner iD

Contact Dermatitis · 2023

DOI: 10.1111/cod.14309 ↗

At a glance

Journal article in Contact Dermatitis, 2023. Written by Esen Özkaya and 2 co-authors. Institution: Istanbul Faculty of Medicine, Department of Dermatology and Venereology, Istanbul University, Istanbul, Turkey. Major MEDLINE topics: Dermatitis, Allergic Contact. Cited 8 times so far (Crossref); 35 references.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

Allergic contact dermatitis (ACD) from topical ophthalmic medications (TOMs) poses an additional disease burden to patients who already suffer from eye problems.

Objectives

To investigate the epidemiological/clinical profile of patients with periorbital ACD from TOMs in Turkey. Patients and Methods This was a retrospective, cross‐sectional, single tertiary centre study based on files of 75 patch tested patients with suspected periorbital ACD from TOMs among a total of 2801 consecutively patch tested patients with suspected ACD of any origin between 1996 and 2019.

Results

Periorbital ACD was diagnosed in 25 of 75 (33.3%) patients (female:male = 1.8:1; age range: 6–85 years) with suspected ACD from TOMs showing an overall prevalence of 0.9% (25/2801) among the whole patch test population. Atopy was not present. Tobramycin‐containing TOMs were the most frequent culprits, followed by antiglaucoma preparations. Their frequency increased, whereas no new cases of neomycin‐induced ACD were observed after 2011. Positivities with thimerosal were of unknown clinical relevance, while benzalkonium chloride (BAC) caused ACD in two patients. The diagnosis would be missed in each 20% of patients without performing day (D) 4 and D7 readings and strip‐patch testing. Ten culprits were identified only by testing with patients' own TOMs in eight (32%) patients.

Conclusions

Aminoglycosides, particularly tobramycin, were the leading cause of ACD from TOMs. The frequency of ACD from tobramycin and antiglaucoma medications increased after 2011. BAC was a rare but important allergen. Additional D4 and D7 readings, strip‐patch testing, and testing with patients' own TOMs seem essential when patch testing with eye medications.

Subjects

MeSH terms (MEDLINE)

Dermatitis, Allergic ContactHumansMaleFemaleChildAdolescentYoung AdultAdultMiddle AgedAgedAged, 80 and overAntiglaucoma AgentsTobramycinRetrospective StudiesCross-Sectional StudiesTurkeyAllergensBenzalkonium CompoundsPatch Tests

Author keywords

allergic contact dermatitisaminoglycosideantiglaucomaeyelidlate readingpatch testperiorbitalstrip-patch testtape-strippingtopical ophthalmic medications

Substances

Antiglaucoma AgentsTobramycinAllergensBenzalkonium Compounds

Authors and institutions

  • Istanbul Faculty of Medicine, Department of Dermatology and Venereology, Istanbul University, Istanbul, Turkey.
  • Faculty of Medicine, Department of Dermatology and Venereology, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.

ORCID profiles: Esen Özkaya, Zeynep Keskinkaya, Goncagül Babuna Kobaner

Cite

APA

Özkaya, E., Keskinkaya, Z., & Babuna Kobaner, G. (2023). Tobramycin and antiglaucoma agents as increasing culprits of periorbital allergic contact dermatitis from topical ophthalmic medications: A 24‐year study from Turkey. Contact Dermatitis. https://doi.org/10.1111/cod.14309

Vancouver

Özkaya E, Keskinkaya Z, Babuna Kobaner G. Tobramycin and antiglaucoma agents as increasing culprits of periorbital allergic contact dermatitis from topical ophthalmic medications: A 24‐year study from Turkey. Contact Dermatitis. 2023. doi:10.1111/cod.14309

BibTeX
@article{zkaya2023,
  author = {Özkaya, Esen and Keskinkaya, Zeynep and Babuna Kobaner, Goncagül},
  title = {Tobramycin and antiglaucoma agents as increasing culprits of periorbital allergic contact dermatitis from topical ophthalmic medications: A 24‐year study from Turkey},
  journal = {Contact Dermatitis},
  year = {2023},
  doi = {10.1111/cod.14309}
}
Start for free →